Goldman Sachs vs Charles Schwab
Add, change or remove companies; up to four.
The short version
- Goldman Sachs is the larger business, with $58.3B of revenue in fiscal 2025 against $23.9B for Charles Schwab, about 2.4 times as much.
- Charles Schwab grew revenue faster (22.0%, against 8.9%).
- Investors pay more for each dollar of Charles Schwabβs earnings: a P/E of 16.5x against 13.5x for Goldman Sachs.
| Latest fiscal year | GS Β· FY25 | SCHW Β· FY25 |
|---|---|---|
| Size | ||
| Market cap | $278.1B | $163.9B |
| Revenue | $58.3B | $23.9B |
| Free cash flow | β | β |
| Net income | $17.2B | $8.9B |
| Growth | ||
| Revenue growth | 8.9% | 22.0% |
| 5-year growth | 5.5% | 15.4% |
| Share count change | β4.8% | β1.4% |
| Profitability | ||
| Gross margin | β | β |
| Operating margin | β | β |
| Net margin | 29.5% | 37.0% |
| FCF margin | β | β |
| Return on capital | β | β |
| Return on equity | 13.9% | 18.1% |
| Balance sheet | ||
| Net debt | β | β |
| Net debt / EBITDA | β | β |
| Dividends and buybacks | $17.6B | $9.7B |
| Valuation & quality | ||
| P/E | 13.5x | 16.5x |
| Piotroski F-score | β | β |
Revenue
FY16
GS $30.8B
SCHW $7.5B
FY17
GS $32.7B
SCHW $8.6B
FY18
GS $36.6B
SCHW $10.1B
FY19
GS $36.5B
SCHW $10.7B
FY20
GS $44.6B
SCHW $11.7B
FY21
GS $59.3B
SCHW $18.5B
FY22
GS $47.4B
SCHW $20.8B
FY23
GS $46.3B
SCHW $18.8B
FY24
GS $53.5B
SCHW $19.6B
FY25
GS $58.3B
SCHW $23.9B
GS
SCHW
Operating margin
FY16
GS β
SCHW β
FY17
GS β
SCHW β
FY18
GS β
SCHW β
FY19
GS β
SCHW β
FY20
GS β
SCHW β
FY21
GS β
SCHW β
FY22
GS β
SCHW β
FY23
GS β
SCHW β
FY24
GS β
SCHW β
FY25
GS β
SCHW β
GS
SCHW
Free cash flow
FY16
GS β
SCHW β
FY17
GS β
SCHW β
FY18
GS β
SCHW β
FY19
GS β
SCHW β
FY20
GS β
SCHW β
FY21
GS β
SCHW β
FY22
GS β
SCHW β
FY23
GS β
SCHW β
FY24
GS β
SCHW β
FY25
GS β
SCHW β
GS
SCHW
Return on capital
FY16
GS β
SCHW β
FY17
GS β
SCHW β
FY18
GS β
SCHW β
FY19
GS β
SCHW β
FY20
GS β
SCHW β
FY21
GS β
SCHW β
FY22
GS β
SCHW β
FY23
GS β
SCHW β
FY24
GS β
SCHW β
FY25
GS β
SCHW β
GS
SCHW
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.